Which members of Congress have traded BCRX?

1 member of Congress has disclosed 1 trade in BioCryst Pharmaceuticals, Inc. (BCRX) under the STOCK Act: Josh Gottheimer.

When was BCRX most recently disclosed by Congress?

The most recent BCRX disclosure was a purchase by Josh Gottheimer on 11 August 2022.

What is the total disclosed congressional trading volume for BCRX?

Members of Congress have disclosed approximately $8K in BCRX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).

How can I track new congressional trades in BCRX?

This BCRX page updates as soon as new STOCK Act disclosures are filed for BioCryst Pharmaceuticals, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS • Currently up 0.13 (+1.47%) in today's trading session

1 member of Congress has disclosed 1 trade in BioCryst Pharmaceuticals, Inc. (BCRX) via STOCK Act filings. The most recent disclosure was a purchase by Josh Gottheimer on 11 August 2022. Aggregate disclosed activity totals roughly $8K in purchases (midpoint estimates from bracketed disclosure amounts).

BioCryst Pharmaceuticals, Inc. is currently trading at $8.99, positioned at 56% of its 52-week range ($6.00 – $11.31).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only

Copy Portfolio Claim Free Asset

Live portfolio tracking

Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price

$8.99

24h Change

+0.13 (+1.47%)

52 Week Range

$6.00—$11.31

View on NASDAQ

BioCryst Pharmaceuticals, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BCRX

Select to highlight on chart

Politician

1 transactions

Include Non-Compliant

Compliance: 100%


	Josh Gottheimer	11 Aug 2022	16 Sept 2022	Purchase	Stock	$1,001 - $15,000	N/A

Select transactions to view their annotations on the chart

Earnings

Next Report

Q1 2026

6 May

EPS Est.

$0.06

Rev. Est.

$151.1M

Days Until

Recent Quarters

Q4 202526 Feb

EPS$1.12

Beat 1500.0%

Q3 20253 Nov

EPS$0.06

Miss 14.3%

Q2 20254 Aug

EPS$0.15

Beat 400.0%

Q1 20255 May

EPS$0.00

Beat 100.2%

Q4 202424 Feb

EPS$-0.13

Miss 85.7%

Q3 20244 Nov

EPS$-0.07

Beat 0.0%

Q2 20245 Aug

EPS$-0.06

Beat 68.4%

Q1 20246 May

EPS$-0.17

Beat 26.1%

Q4 202326 Feb

EPS$-0.28

Miss 16.7%

Q3 20232 Nov

EPS$-0.19

Beat 24.0%

Q2 20233 Aug

EPS$-0.24

Beat 4.0%

Q1 20233 May

EPS$-0.28

Beat 6.7%

Q4 202221 Feb

EPS$-0.38

Miss 100.0%

Q3 20221 Nov

EPS$-0.23

Beat 28.1%

Q2 20224 Aug

EPS$-0.32

Beat 11.1%

Q1 20225 May

EPS$-0.40

Miss 2.6%

Q4 202123 Feb

EPS$-0.40

Miss 29.0%

Q3 20213 Nov

EPS$-0.33

Miss 10.0%

Q2 20215 Aug

EPS$-0.24

Miss 9.1%

Q1 20216 May

EPS$-0.36

Miss 38.5%

Q4 202025 Feb

EPS$-0.34

Miss 36.0%

Q3 20205 Nov

EPS$-0.26

Miss 4.0%

Q2 20206 Aug

EPS$-0.24

Beat 14.3%

Q1 20206 May

EPS$-0.24

Beat 7.7%

Q4 20195 Mar

EPS$-0.02

Beat 92.0%

Q3 20196 Nov

EPS$-0.34

Miss 9.7%

Q2 20196 Aug

EPS$-0.34

Miss 9.7%

Q1 20198 May

EPS$-0.28

Beat 0.0%

Q4 20184 Mar

EPS$-0.25

Beat 3.9%

Q3 20186 Nov

EPS$-0.28

Miss 12.0%

Q2 20187 Aug

EPS$-0.19

Beat 17.4%

Q1 20188 May

EPS$-0.26

Miss 62.5%

Q4 201727 Feb

EPS$-0.20

Miss 42.9%

Q3 20177 Nov

EPS$-0.18

Miss 5.9%

Q2 20177 Aug

EPS$-0.21

Miss 10.5%

Q1 20174 May

EPS$-0.19

Beat 5.0%

Q4 201627 Feb

EPS$-0.06

Beat 76.0%

Q3 20167 Nov

EPS$-0.16

Beat 30.4%

Q2 20164 Aug

EPS$-0.22

Beat 8.3%

Q1 20165 May

EPS$-0.31

Miss 34.8%

Q4 201523 Feb

EPS$-0.25

Beat 0.0%

Q3 20155 Nov

EPS$-0.20

Beat 0.0%

Q2 20157 Aug

EPS$0.06

Beat 127.3%

Q1 20158 May

EPS$-0.21

Beat 12.5%

Q4 201418 Feb

EPS$-0.16

Beat 20.0%

Q3 20146 Nov

EPS$-0.12

Beat 36.8%

Q2 20145 Aug

EPS$-0.23

Miss 21.1%

Q1 20148 May

EPS$-0.17

Miss 6.3%

Q4 201326 Feb

EPS$-0.09

Beat 18.2%

Q3 20135 Nov

EPS$-0.14

Miss 7.7%

Q2 20138 Aug

EPS$-0.23

Miss 91.7%

Q1 20137 May

EPS$-0.09

Beat 25.0%

Q4 201219 Feb

EPS$-0.20

Beat 20.0%

Q3 20128 Nov

EPS$-0.19

Beat 24.0%

Q2 20122 Aug

EPS$-0.25

Beat 3.9%

Q1 20127 May

EPS$-0.13

Beat 50.0%

Q4 201116 Feb

EPS$-0.29

Miss 3.6%

Q3 20112 Nov

EPS$-0.32

Miss 23.1%

Q2 20114 Aug

EPS$-0.36

Miss 44.0%

Q1 20114 May

EPS$-0.29

Miss 45.0%

Q4 201010 Feb

EPS$-0.20

Beat 4.8%

Q3 201028 Oct

EPS$-0.24

Miss 41.2%

Q2 20105 Aug

EPS$-0.23

Miss 4.5%

Q1 201028 Apr

EPS$-0.06

Beat 62.5%

Q4 20094 Feb

EPS$0.35

Beat 288.9%

Q3 200929 Oct

EPS$-0.28

Miss 27.3%

Q2 200930 Jul

EPS$-0.23

Beat 8.0%

Q1 20098 May

EPS$-0.24

Beat 14.3%

Q4 20086 Feb

EPS$0.26

Beat 218.2%

Q3 200831 Oct

EPS$-0.24

Beat 0.0%

Q2 20087 Aug

EPS$-0.33

Miss 65.0%

Q1 20088 May

EPS$-0.34

Miss 88.9%

Q4 20074 Mar

EPS$-0.06

Beat 84.6%

Q3 20078 Nov

EPS$-0.32

Miss 14.3%

Q2 20079 Aug

EPS$-0.24

Beat 27.3%

Q1 20079 May

EPS$-0.30

Miss 11.1%

Q4 20067 Feb

EPS$-0.34

Beat 32.0%

Q3 20068 Nov

EPS$-0.53

Miss 29.3%

Q2 20069 Aug

EPS$-0.35

Miss 20.7%

Q1 200627 Apr

EPS$-0.27

Miss 12.5%

Q4 20058 Feb

EPS$-0.27

Beat 6.9%

Q3 200526 Oct

EPS$-0.29

Miss 20.8%

Q2 20053 Aug

EPS$-0.22

Beat 12.0%

Q1 200521 Apr

EPS$-0.24

Beat 0.0%

Q4 20042 Feb

EPS$-0.24

Beat 7.7%

Q3 200420 Oct

EPS$-0.24

Beat 0.0%

Q2 200421 Jul

EPS$-0.23

Beat 17.9%

Q1 200421 Apr

EPS$-0.28

Miss 27.3%

Q4 200319 Mar

EPS$-0.17

Q4 20034 Feb

EPS$-0.18

Beat 10.0%

Q2 200313 Aug

EPS$-0.18

Q1 20039 May

EPS$-0.16

Q4 200221 Mar

EPS$-0.15

Q3 200212 Nov

EPS$-0.19

Q2 20027 Aug

EPS$-0.29

Q1 20023 May

EPS$-0.32

Q4 200130 Jan

EPS$-0.28

Miss 100.0%

Q3 200124 Oct

EPS$0.02

Beat 115.4%

Q2 200125 Jul

EPS$-0.08

Beat 33.3%

Q1 200125 Apr

EPS$-0.08

Beat 27.3%

Q4 20001 Feb

EPS$-0.11

Beat 8.3%

Q3 200025 Oct

EPS$-0.09

Beat 18.2%

Q2 200026 Jul

EPS$-0.11

Beat 8.3%

Q1 200026 Apr

EPS$0.10

Beat 385.7%

Q4 19992 Feb

EPS$-0.03

Miss 125.1%

Q3 199921 Oct

EPS$-0.15

Beat 16.7%

Q2 199913 Aug

EPS$-0.02

Q2 199921 Jul

EPS$-0.02

Beat 75.0%

Q4 199827 Jan

EPS$-0.10

Beat 58.3%

Q3 199828 Oct

EPS$0.19

Beat 5.6%

Q2 199814 Aug

EPS$-0.21

Q2 199822 Jul

EPS$-0.21

Beat 16.0%

Q4 199724 Mar

EPS$-0.21

Q4 19973 Feb

EPS$-0.21

Beat 8.7%

Q2 19975 Aug

EPS$-0.15

Q1 199728 Apr

EPS$-0.23

Miss 91.7%

Q4 199610 Feb

EPS$-0.15

Beat 28.6%

Q3 199629 Oct

EPS$-0.23

Beat 17.9%

Q2 199625 Jul

EPS$-0.11

Miss 320.0%

Q1 199624 Apr

EPS$-0.20

Beat 23.1%

Q4 199529 Jan

EPS$-0.23

Beat 11.5%

Q3 199517 Oct

EPS$-0.20

Beat 13.0%

Q2 199525 Jul

EPS$-0.18

Beat 45.5%

Q1 199528 Apr

EPS$-0.37

Miss 19.4%

Q4 199431 Jan

EPS$-0.24

Beat 7.7%

Q3 199426 Oct

EPS$-0.22

Beat 29.0%

Q2 19942 Aug

EPS$-0.25

Beat 24.2%

Q1 199430 Jun

EPS$-0.25

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

NVDA

NVIDIA Corporation

$209.25-3.82 (-1.79%)

Technology

Held by same politician

Significant holdings value

1 politician

View Stock

PTSNX

PIMCO Short Term I-3

$9.680.00 (0.00%)

Held by same politician

1 politician

View Stock

NFLX

Netflix, Inc.

$92.12-0.17 (-0.19%)

Communication Services

Held by same politician

1 politician

View Stock

Frequently Asked Questions about BCRX

Which members of Congress have traded BCRX?: 1 member of Congress has disclosed 1 trade in BioCryst Pharmaceuticals, Inc. (BCRX) under the STOCK Act: Josh Gottheimer.
When was BCRX most recently disclosed by Congress?: The most recent BCRX disclosure was a purchase by Josh Gottheimer on 11 August 2022.
What is the total disclosed congressional trading volume for BCRX?: Members of Congress have disclosed approximately $8K in BCRX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in BCRX?: This BCRX page updates as soon as new STOCK Act disclosures are filed for BioCryst Pharmaceuticals, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.

BioCryst Pharmaceuticals, Inc. (BCRX)

Want to automatically copy Pelosi trades?

BioCryst Pharmaceuticals, Inc. Price History and Technical Analysis

Congressional Trading Activity for BCRX

Stock Overview

Market Data

Fundamentals

Company Information

Earnings

Next Report

Recent Quarters

Similar Stocks

NVDA

PTSNX

NFLX

Frequently Asked Questions about BCRX

BioCryst Pharmaceuticals, Inc. (BCRX)

Want to automatically copy Pelosi trades?

BioCryst Pharmaceuticals, Inc. Price History and Technical Analysis

Congressional Trading Activity for BCRX

Stock Overview

Market Data

Fundamentals

Company Information

Earnings

Next Report

Recent Quarters

Similar Stocks

NVDA

PTSNX

NFLX

Frequently Asked Questions about BCRX

Track BCRX in Congress